查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1641812

全球血糖仪市场按类型和最终用户划分 - 机会分析和行业预测，2024 年至 2033 年

Glucose Meter Market By Type (Traditional Glucose Meters, Smart Glucose Meters) , By End User (Hospitals, Clinics, Home Care Settings) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3个工作天内

价格
简介目录

血糖仪市场规模预计在 2023 年达到 10 亿美元，到 2033 年将达到 17 亿美元，2024 年至 2033 年的复合年增长率为 5.4%。

血糖仪市场-IMG1

血糖仪，也称为血糖仪，是一种用于测量血液中葡萄糖浓度的便携式医疗设备。糖尿病患者通常使用它们来监测血糖值，帮助他们有效地管理病情。该设备需要刺穿手指以获取少量血样，然后进行分析以提供即时血糖读数。

全球血糖仪市场正在经历强劲增长，原因包括公众对定期血糖值监测和早期诊断重要性的认识不断提高，以及久坐的生活方式和不健康的饮食习惯导致糖尿病患病率急剧上升。根据国际糖尿病联盟（IDF）2021年发布的调查显示，全球约有5.37亿成年人（20-79岁）患有糖尿病。预计到2030年这数字将达到6.43亿，到2045年将达到7.83亿。这凸显了对血糖仪持续监测血糖浓度的迫切需求。此外，人们对家庭医疗保健解决方案的日益偏好推动了对可携式和易于使用的血糖仪的需求，从而推动了市场成长。此外，老年人口的快速增加将成为全球市场的主要动力。这是因为老龄化人口更容易患糖尿病和相关併发症，从而增加了对有效血糖监测解决方案的需求。世界卫生组织（WHO）发布的2024年调查显示，老年人口数量将从2020年的10亿增加到2030年的14亿。此外，到2050年，80岁及以上人口数量预计将达到4.26亿人。新兴市场医疗保健基础设施的改善和可支配收入的增加进一步增加了血糖监测设备的使用机会，从而推动了市场的成长。然而，连续血糖监测仪等先进血糖监测系统的高成本正在抑制市场的成长。此外，缺乏对糖尿病管理和定期血糖监测重要性的认识限制了对血糖仪的需求。相反，连续血糖监测仪、智慧型手机仪表和非侵入式设备等创新血糖监测技术的发展正在提高准确性、便利性和易用性。预计这些发展将为预测期内全球市场的扩张开闢新的途径。

全球血糖仪产业分为类型、最终用户和地区。根据类型，市场分为传统血糖仪和智慧血糖仪。根据最终用户，市场分为医院、诊所和居家医疗。按地区分析，涵盖北美、欧洲、亚太、拉丁美洲以及中东和非洲。

主要发现

按类型划分，传统血糖仪预计将在 2024 年至 2033 年期间占据市场主导地位。

根据最终用户，医院部门预计在预测期内呈现最高成长。

根据地区，预计未来几年血糖仪市场在北美将呈现强劲成长。

此报告可自订。 （需要额外的费用和时间表。）

  • 监管指南
  • 根据客户兴趣提供额外的公司简介
  • 导入/汇出分析/资料
  • 赎回情况

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 重大投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会

第四章 血糖机市场类型

  • 市场概况
  • 传统血糖仪
  • 智慧型血糖仪

第 5 章 血糖仪市场（依最终用户）

  • 市场概况
  • 医院
  • 诊所
  • 居家医疗

6. 血糖仪市场（按地区）

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国血糖仪市场
    • 加拿大血糖机市场
    • 墨西哥的血糖仪市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国血糖机市场
    • 德国血糖仪市场
    • 义大利血糖机市场
    • 西班牙血糖仪市场
    • 英国血糖仪市场
    • 其他欧洲国家血糖仪市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国血糖仪市场
    • 日本血糖仪市场
    • 印度血糖仪市场
    • 韩国血糖仪市场
    • 澳洲血糖仪市场
    • 其他亚太地区血糖仪市场
  • 拉丁美洲、中东和非洲
    • 主要市场趋势和机会
    • 巴西血糖仪市场
    • 南非血糖仪市场
    • 沙乌地阿拉伯血糖仪市场
    • 拉丁美洲、中东和非洲其他地区的血糖仪市场

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 家公司的产品映射
  • 竞争仪錶板
  • 竞争热图
  • 2023年主要企业的定位

第八章 公司简介

  • B. Braun SE
  • F. Hoffmann-La Roche Ltd
  • AgaMatrix, Inc
  • Ascensia Diabetes Care
  • LifeScan IP Holdings, LLC.
  • Medtronic
  • Dexcom, Inc.
  • Ypsomed.
  • Abbott Laboratories
  • Terumo Corporation
简介目录
Product Code: A324427

The glucose meter market was valued at $1.0 billion in 2023, and is projected to reach $1.7 billion by 2033, growing at a CAGR of 5.4% from 2024 to 2033.

Glucose Meter Market - IMG1

A glucose meter, also known as a glucometer, is a portable medical device designed to measure the concentration of glucose in the blood. It is commonly used by individuals with diabetes to monitor their blood sugar levels, helping them manage their condition effectively. The device requires a small blood sample, obtained via a finger prick, which is then analyzed to provide real-time glucose readings.

The global glucose meter market is witnessing robust growth due to factors such as increase in public awareness about the importance of regular blood glucose monitoring and early diagnosis and alarming rise in prevalence of diabetes driven by sedentary lifestyle and unhealthy diets. As per a study published in 2021 by the International Diabetes Federation (IDF), approximately 537 million adults (20-79 years) were suffering from diabetes. This number is estimated to reach 643 million by 2030 and 783 million by 2045. This highlights the urgent need for glucose meters for continuous monitoring of glucose levels. In addition, rise in preference for home-based healthcare solutions has driven the demand for portable and easy-to-use glucose meters, thereby fostering the market growth. Furthermore, surge in geriatric population acts as a key driving force of the global market. This is attributed to the fact that the aging population is more susceptible to diabetes and related complications, creating a growing need for efficient glucose monitoring solutions. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. Improved healthcare infrastructure and rise in disposable incomes in emerging markets have further enhanced access to glucose monitoring devices, driving the market growth. However, high cost associated with advanced glucose monitoring systems, such as continuous glucose monitors, restrains the market growth. In addition, lack awareness about diabetes management and the importance of regular glucose monitoring limits the demand for glucose meters. On the contrary, the development of innovative glucose monitoring technologies, such as continuous glucose monitors, smartphone-compatible meters, and non-invasive devices has enhanced accuracy, convenience, and user-friendliness. Such developments are expected to open new avenues for the expansion of the global market during the forecast period.

The global glucose meter industry is segmented into type, end user, and region. On the basis of type, the market is categorized into traditional glucose meters and smart glucose meters. Depending on end user, it is segregated into hospitals, clinics, and home care settings. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the traditional glucose meters segment is expected to dominate the market from 2024 to 2033.

On the basis of end user, the hospitals segment is anticipated to exhibit the highest growth during the forecast period.

Region wise, the blood glucose meter market is projected to show strong growth in North America in the coming years.

Competition Analysis

The major players operating in the global glucose meter market include B. Braun SE, F. Hoffmann-La Roche Ltd, AgaMatrix, Inc, Ascensia Diabetes Care, LifeScan IP Holdings, LLC., Medtronic, Dexcom, Inc., Ypsomed., Abbott Laboratories, and Terumo Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Import Export Analysis/Data
  • Reimbursement Scenario

Key Market Segments

By Type

  • Traditional Glucose Meters
  • Smart Glucose Meters

By End User

  • Hospitals
  • Clinics
  • Home Care Settings

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • B. Braun SE
    • F. Hoffmann-La Roche Ltd
    • AgaMatrix, Inc
    • Ascensia Diabetes Care
    • LifeScan IP Holdings, LLC.
    • Medtronic
    • Dexcom, Inc.
    • Ypsomed.
    • Abbott Laboratories
    • Terumo Corporation

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: GLUCOSE METER MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Traditional Glucose Meters
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Smart Glucose Meters
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: GLUCOSE METER MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Clinics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Home Care Settings
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: GLUCOSE METER MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Glucose Meter Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Glucose Meter Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Glucose Meter Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Glucose Meter Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. Germany Glucose Meter Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. Italy Glucose Meter Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Spain Glucose Meter Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. UK Glucose Meter Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest Of Europe Glucose Meter Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Glucose Meter Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. Japan Glucose Meter Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Glucose Meter Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. South Korea Glucose Meter Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. Australia Glucose Meter Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Glucose Meter Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Glucose Meter Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. South Africa Glucose Meter Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. Saudi Arabia Glucose Meter Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Glucose Meter Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping Of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. B. Braun SE
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. F. Hoffmann-La Roche Ltd
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. AgaMatrix, Inc
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Ascensia Diabetes Care
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. LifeScan IP Holdings, LLC.
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Medtronic
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Dexcom, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Ypsomed.
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Abbott Laboratories
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Terumo Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments